•
Dec 31, 2023

AbCellera Q4 2023 Earnings Report

Reported Q4 2023 financial results, showing a decrease in revenue compared to the previous year, but advancements in internal programs and strategic partnerships.

Key Takeaways

AbCellera reported Q4 2023 revenue of $9.2 million, representing 24% of the total revenue for 2023. The company experienced a net loss of $47.2 million, or $(0.16) per share. They advanced two internal programs into IND-enabling studies and saw three partner-initiated programs start with downstreams.

Q4 revenue was $9.2 million, 24% of total revenue for 2023.

$8.7 million was generated from research fees.

Net loss for Q4 was $47.2 million, or $(0.16) per share.

Advanced two internal programs into IND-enabling studies: ABCL635 and ABCL575.

Total Revenue
$9.18M
Previous year: $21.5M
-57.4%
EPS
-$0.16
Previous year: -$0.1
+60.0%
Gross Profit
$70K
Previous year: $20M
-99.6%
Cash and Equivalents
$133M
Previous year: $44.9M
+196.9%
Free Cash Flow
-$32.6M
Previous year: $18.6M
-275.4%
Total Assets
$1.49B
Previous year: $1.54B
-3.4%

AbCellera

AbCellera

AbCellera Revenue by Segment

Forward Guidance

AbCellera is shifting capital allocation from building capabilities to using them, which includes advancement of our first internal programs and strategic partnerships.